Ms Bioworks News Today

Proteomics Market worth $55.9 billion by 2026 – Segments, Opportunities, Growth, Size and Key Players Analysis

Proteomics Market worth $55.9 billion by 2026 – Segments, Opportunities, Growth, Size and Key Players Analysis

Proteomics Market worth $55.9 billion by 2026 iCrowd Newswire According to the new market research report by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecast to 2026″, published by MarketsandMarkets™, the Proteomics Market is valued at an estimated USD 25.9 billion in 2021 and is projected to reach USD 55.9 bill...

Share this article Share this article Jersey City, N.J., June 9, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Proteomics Market" By Reagent (Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents & Others), By Instrumentation Technology (X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation & Others), By Software and Service (Core Proteomics Services and Bioinformatics Software and Services), By Application ...

- The growth of the market can be attributed to a growth in research activities surrounding personalized medicine, increasing investments in R&D by Pharmaceutical and Biotechnology Companies

Proteomics Market worth $55.9 billion by 2026 - Exclusive Report by MarketsandMarkets "Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecast to 2026", published by MarketsandMarkets, the Proteomics Market is valued at an estimated USD 25.9 billion in 2021 and is projected to reach USD 55.9 billion by ...

An increase in the research activity, especially in the area of personalized medicine and drug discovery, is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the market growth. The core proteomics services segment accounted for the largest share of the proteomics market, by product segment, in 2020 Based on service and software, t...